Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor Medical Systems, Inc.’s TriGrid to be Presented at AIDS Conference

SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced TriGrid™ Delivery System is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today that preliminary safety and tolerability data for a Phase I preventive HIV vaccine clinical trial being conducted at the Rockefeller University Hospital in New York City will be presented at the AIDS Vaccine Conference in Cape Town South Africa this week. Recruitment of trial participants, comprised of healthy HIV-negative volunteers, is now complete.